Longitude Capital Associates, L.P.'s Net Worth

$459 Million

Estimate Recalculated Feb 21, 2024 09:14PM EST

Who is Longitude Capital Associates, L.P.?

Longitude Capital Associates, L.P. has an estimated net worth of $459 Million. This is based on reported shares across multiple companies, which include CORCEPT THERAPEUTICS INC, COLLEGIUM PHARMACEUTICAL, INC, and Esperion Therapeutics, Inc..

SEC CIK

Longitude Capital Associates, L.P.'s CIK is 0001430719

Past Insider Trading and Trends

2015 was Longitude Capital Associates, L.P.'s most active year for acquiring shares with 10 total transactions. Longitude Capital Associates, L.P.'s most active month to acquire stocks was the month of February. 2014 was Longitude Capital Associates, L.P.'s most active year for disposing of shares, totalling 26 transactions. Longitude Capital Associates, L.P.'s most active month to dispose stocks was the month of October. 2015 saw Longitude Capital Associates, L.P. paying a total of $12,133,536.06 for 6,439,904 shares, this is the most they've acquired in one year. In 2017 Longitude Capital Associates, L.P. cashed out on 1,000,000 shares for a total of $17,340,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

COLLEGIUM PHARMACEUTICAL, INC (COLL) Snapshot price: $33.265

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-30.10%
-1.00M
$17.34
-$17,340,000.00
2.32M
Dec 8
Form 4
3.32M
$12.00
3.32M
May 12
Form 3
0
0
No matching records found

CORCEPT THERAPEUTICS INC (CORT) Snapshot price: $22.02

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-21.50%
-3.00M
10.96M
Nov 28
Form 4
-0.26%
-36.94K
$9.34
-$345,165.30
13.96M
Nov 22 - Nov 25
Form 4
-3.74%
-544.10K
$9.56
-$5,199,426.22
13.99M
Nov 17 - Nov 21
Form 4
-1.19%
-174.85K
$9.55
-$1,669,605.81
14.54M
Nov 15 - Nov 16
Form 4
+6.18%
856.64K
$4.05
$3,469,408.20
14.71M
Mar 30
Form 4
+9.24%
1.17M
$4.29
-$10.79
13.86M
Mar 20 - Mar 24
Form 4
-0.97%
-250.00K
$4.10
-$1,026,569.45
25.45M
May 1 - May 2
Form 4
-1.90%
-250.00K
$4.28
-$1,070,575.00
12.93M
Apr 1
Form 4
-0.63%
-250.00K
$4.00
-$1,000,818.05
39.74M
Mar 5 - Mar 7
Form 4
+6.81%
856.64K
$2.96
$2,535,666.24
13.43M
Mar 29
Form 4
+6.34%
750K
$3.90
$2,925,000.00
12.58M
Jan 21
Form 4
+7.81%
856.64K
$1.66
$1,422,029.04
11.83M
Apr 21
Form 4
+28.72%
2.45M
$1.38
$3,377,623.14
10.97M
Oct 16
Form 4
+119.67%
4.64M
$0.69
$3,189,642.76
8.52M
Feb 6
Form 4
+9.90%
349.43K
$1.45
$506,666.25
3.88M
Nov 11
Form 3
0
0
No matching records found

Esperion Therapeutics, Inc. (ESPR) Snapshot price: $2.655

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-25.35%
-487.13K
$32.78
-$15,966,168.16
1.43M
Nov 17 - Nov 18
Form 4
-0.05%
-943.00
$30.00
-$28,290.00
1.92M
Oct 9
Form 4
-0.62%
-11.93K
$30.04
-$358,289.49
1.92M
Oct 7
Form 4
1.93M
$14.00
1.93M
Jul 1
Form 3
0
0
No matching records found